HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Outsourcing

1,815.898

-86.105-4.53%

Number of Gainers:1

Number of Losers:7

Number of Flat:- -

PE:- -

High:1,916.252

Open:1,900.655

Low:1,795.033

Close:1,902.003

Loading ...

Individual investors who have a significant stake must be disappointed along with institutions after WuXi Biologics (Cayman) Inc.'s (HKG:2269) market cap dropped by HK$12b

Simply Wall St.

China's Healthcare Industry Likely Not Concerned About U.S. Tariffs -- Market Talk

WuXi AppTec Offloads 4.23% Stake in WuXi XDC Cayman

MT Newswires Live

BRIEF-WuXi AppTec Announces Disposal Of Certain Share Assets In WuXi XDC

WuXi AppTec - Aggregate Realized Investment Gains From Disposal Is RMB1.847 Bln

THOMSON REUTERS

WuXi AppTec - Disposal of Certain Share Assets

THOMSON REUTERS

WuXi AppTec - Aggregate Transaction Amount Approximately HK$2.178 Bln

THOMSON REUTERS

WuXi AppTec - Continued to Dispose of 50.8 Mln Shares in WuXi XDC via Block Trade

THOMSON REUTERS

Viva Biotech Holdings' (HKG:1873) Shares Bounce 29% But Its Business Still Trails The Industry

Simply Wall St.

Viva Biotech's Pharma Unit Passes US FDA Onsite Inspection

MT Newswires Live

Press Release: Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D

BRIEF-Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical

VIVA Biotech - Passing of U.S. FDA on-Site Inspection by Langhua Pharmaceutical

THOMSON REUTERS

VIVA Biotech Holdings FY Revenue RMB 1,986.7 Million

THOMSON REUTERS

VIVA Biotech Holdings FY Gross Profit RMB 687.4 Million

THOMSON REUTERS

BRIEF-Frontage Holdings Corp Posts FY Net Income USD 0.6 Million

Rpt-Frontage Holdings Corp FY Ebitda Margin 19.6%

THOMSON REUTERS

Corrected-Frontage Holdings Corp FY Net Income USD 0.6 Million (Corrects Amount)

THOMSON REUTERS

Frontage Holdings Corp FY Gross Margin 27.4%

THOMSON REUTERS

Frontage Holdings Corp FY Revenue USD 254.9 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1576/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"Pharmaceutical Outsourcing","latestPrice":1815.8982,"timestamp":1743667695010,"preClose":1902.003,"halted":0,"volume":146135488,"delay":0,"changeRate":-0.045271,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-86.104858,"latestTime":"04-03 16:00:00","open":1900.6554,"high":1916.2518,"low":1795.0331,"amount":3612573229,"amplitude":0.063732,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"pbRate":2.250114,"peRate":11.036581,"turnoverRate":0.012477,"increases":1,"decrements":7,"flats":0,"marketCap":383114931968,"floatMarketCap":169181056128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":1916.2518,"amplitude":0.063732,"preClose":1902.003,"low":1795.0331,"pbRate":"2.250114","latestPrice":1815.8982,"volume":146135488,"delay":0,"open":1900.6554,"prevYearClose":1395.7731,"prevWeekClose":1942.366,"prevMonthClose":1941.338,"prevQuarterClose":1941.338,"fiveDayClose":1994.557,"twentyDayClose":1772.232,"sixtyDayClose":1318.43,"secType":"PLATE","market":"HK","turnoverRate":0.012477,"peRate":11.036581,"marketCap":383114931968,"floatMarketCap":169181056128,"timestamp":1743667695010,"nameCN":"Pharmaceutical Outsourcing"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":1,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524278698","title":"Individual investors who have a significant stake must be disappointed along with institutions after WuXi Biologics (Cayman) Inc.'s (HKG:2269) market cap dropped by HK$12b","url":"https://stock-news.laohu8.com/highlight/detail?id=2524278698","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524278698?lang=en_us&edition=fundamental","pubTime":"2025-04-04 09:04","pubTimestamp":1743728671,"startTime":"0","endTime":"0","summary":"Key Insights WuXi Biologics (Cayman)'s significant individual investors ownership suggests that the key decisions are...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/individual-investors-who-have-a-significant-stake-must-be-di-189","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0140636845.USD","BK1521","LU0456846285.SGD","SG9999002463.SGD","LU0326950275.SGD","LU0516423091.SGD","LU1242518857.USD","LU0417516738.SGD","LU1794554557.SGD","LU0516422366.SGD","LU0052750758.USD","LU0043850808.USD","LU0307460666.USD","LU0516423174.USD","LU1242518931.SGD","LU0516422952.EUR","LU1720050803.USD","LU0181495838.USD","LU0823426308.USD","SG9999002562.SGD","LU2039709279.SGD","LU0979878070.USD","BK1589","LU0819121731.USD","BK1610","LU1880383366.USD","BK1576","LU0327786744.USD","LU0516422440.USD","LU0039217434.USD","BK1141","02269","LU0823426480.USD","LU1688375341.USD","LU0348735423.USD","IE00B0JY6N72.USD","LU0417516902.SGD","LU0348825331.USD","LU0588546209.SGD","LU0320764599.SGD","LU0359201612.USD","LU0856984785.SGD","LU0708995583.HKD","LU0051755006.USD","LU0359202008.SGD","LU0572944931.SGD","LU0456827905.SGD"],"gpt_icon":1},{"id":"2524470838","title":"China's Healthcare Industry Likely Not Concerned About U.S. Tariffs -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2524470838","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524470838?lang=en_us&edition=fundamental","pubTime":"2025-04-03 11:53","pubTimestamp":1743652380,"startTime":"0","endTime":"0","summary":"0353 GMT - President Trump's \"Liberation Day\" tariffs are likely not a big concern for China's healthcare industry, Jefferies analysts say in a research note. Drugs and active pharmaceutical ingredients are exempt from tariffs, and even if Trump imposed any tariffs in the future, most Chinese biotech companies have U.S. partners that are not considered exporters, they say. Contract drug makers, such as the WuXi companies, are in exempt categories as well, they note. \"If the exemption were canceled, the tariff would apply to all non-U.S. competitors, while Chinese players would retain cost and efficiency advantages,\" they say. Medical equipment makers are subject to 54% tariffs, but the analysts reckon the impact will be manageable, as the Chinese makers, such as Mindray Medical International, have low sales exposure to the U.S. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456827905.SGD","BK1576","LU1023057109.AUD","LU1242518931.SGD","LU0417516738.SGD","LU0320764599.SGD","LU0572944931.SGD","603259","LU1688375341.USD","LU2424517915.HKD","BK0251","LU1880383366.USD","LU2039709279.SGD","LU0181495838.USD","BK1589","LU0051755006.USD","LU1146622755.USD","LU0823426480.USD","SGXZ49509284.SGD","LU0052750758.USD","BK4137","BK1521","LU1655091616.SGD","LU0359201612.USD","LU0708995583.HKD","LU0359202008.SGD","LU1997245094.SGD","IE00B031J352.USD","LU2348774022.SGD","LU0043850808.USD","LU0650527681.SGD","LU0979878070.USD","LU0588546209.SGD","LU0594300419.USD","LU2348773727.SGD","SGXZ81163826.USD","IE00B0JY6N72.USD","LU0327786744.USD","LU1720050803.USD","LU0405327148.USD","LU2153592121.USD","BK1141","LU1064131003.USD","LU0823426308.USD","300760","HCSG","LU1580142542.USD","LU0516422952.EUR","LU0456846285.SGD"],"gpt_icon":1},{"id":"2524555469","title":"WuXi AppTec Offloads 4.23% Stake in WuXi XDC Cayman","url":"https://stock-news.laohu8.com/highlight/detail?id=2524555469","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524555469?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:11","pubTimestamp":1743592272,"startTime":"0","endTime":"0","summary":"WuXi AppTec  disposed of a further 50.8 million shares, equivalent to a 4.23% stake, in WuXi XDC Cayman  for around HK$2.18 billion on Tuesday, a Wednesday filing with the Hong Kong bourse said.The drug research and development company previously sold 86 million shares in the target company for roughly HK$2.43 billion on Nov. 8, 2024, and Jan. 10, 2025.The firm will use proceeds from the sale to accelerate the construction of global production capacity and capability, attract and retain outstanding talent, and strengthen its unique integrated CRDMO business model.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0216","LU0320764599.SGD","BK1583","LU1997245177.USD","BK1576","LU0708995583.HKD","LU1046422090.SGD","LU2125910500.SGD","LU2242644610.SGD","02268","LU0456842615.SGD","603259","02359","SG9999014674.SGD","LU0052750758.USD","LU2045819591.USD","LU1997245094.SGD","BK1141","LU2488822045.USD"],"gpt_icon":1},{"id":"2524452940","title":"BRIEF-WuXi AppTec Announces Disposal Of Certain Share Assets In WuXi XDC","url":"https://stock-news.laohu8.com/highlight/detail?id=2524452940","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524452940?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:45","pubTimestamp":1743587114,"startTime":"0","endTime":"0","summary":"BRIEF-WuXi AppTec Announces Disposal Of Certain Share Assets In WuXi XDCApril 2  - WuXi AppTec Co Ltd 603259.SS:DISPOSAL OF CERTAIN SHARE ASSETSAGGREGATE TRANSACTION AMOUNT APPROXIMATELY HK$2.178 BILLIONCONTINUED TO DISPOSE OF 50.8 MILLION SHARES IN WUXI XDC VIA BLOCK TRADEAGGREGATE REALIZED INVESTMENT GAINS FROM DISPOSAL IS RMB1.847 BILLIONFurther company coverage: 603259.SS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF12P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU1046422090.SGD","LU2045819591.USD","LU0456842615.SGD","LU0052750758.USD","603259","LU1997245094.SGD","BK0216","BK1141","BK1583","LU2125910500.SGD","LU0320764599.SGD","BK1576","LU0708995583.HKD","LU2242644610.SGD","LU1997245177.USD","02359"],"gpt_icon":0},{"id":"2524820452","title":"WuXi AppTec - Aggregate Realized Investment Gains From Disposal Is RMB1.847 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2524820452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524820452?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:41","pubTimestamp":1743586890,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF12P:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02359","603259","LU0320764599.SGD","BK1583","LU0456842615.SGD","LU2488822045.USD","LU1997245177.USD","BK1141","LU1997245094.SGD","LU2045819591.USD","LU1046422090.SGD","BK1576","LU2125910500.SGD","BK0216","LU0052750758.USD","LU0708995583.HKD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2524528784","title":"WuXi AppTec -  Disposal of Certain Share Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2524528784","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524528784?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:41","pubTimestamp":1743586890,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF12P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0052750758.USD","LU0456842615.SGD","LU2045819591.USD","BK1576","LU2125910500.SGD","LU0708995583.HKD","LU1046422090.SGD","BK1141","LU1997245094.SGD","LU2242644610.SGD","LU1997245177.USD","LU0320764599.SGD","BK0216","BK1583","02359","LU2488822045.USD","603259"],"gpt_icon":0},{"id":"2524452873","title":"WuXi AppTec -  Aggregate Transaction Amount Approximately HK$2.178 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2524452873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524452873?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:41","pubTimestamp":1743586890,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF12P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0216","LU0708995583.HKD","603259","LU1046422090.SGD","LU2045819591.USD","LU2488822045.USD","BK1583","LU0052750758.USD","LU1997245094.SGD","LU2125910500.SGD","LU1997245177.USD","LU2242644610.SGD","LU0320764599.SGD","LU0456842615.SGD","BK1576","BK1141","02359"],"gpt_icon":0},{"id":"2524452827","title":"WuXi AppTec - Continued to Dispose of 50.8 Mln Shares in WuXi XDC via Block Trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2524452827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524452827?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:41","pubTimestamp":1743586890,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QF12P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0708995583.HKD","BK1576","LU1997245177.USD","LU0052750758.USD","LU0456842615.SGD","BK1141","LU2045819591.USD","LU1997245094.SGD","LU1046422090.SGD","02359","BK0216","LU2488822045.USD","LU2125910500.SGD","LU2242644610.SGD","LU0320764599.SGD","603259","BK1583"],"gpt_icon":0},{"id":"2523640083","title":"Viva Biotech Holdings' (HKG:1873) Shares Bounce 29% But Its Business Still Trails The Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2523640083","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523640083?lang=en_us&edition=fundamental","pubTime":"2025-03-30 08:28","pubTimestamp":1743294531,"startTime":"0","endTime":"0","summary":"Despite an already strong run, Viva Biotech Holdings ( HKG:1873 ) shares have been powering on, with a gain of 29% in...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/viva-biotech-holdings-hkg1873-shares-bounce-29-but-its-busin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VBIZF","BK4121","BK1141","BK1576","01873"],"gpt_icon":1},{"id":"2522925526","title":"Viva Biotech's Pharma Unit Passes US FDA Onsite Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=2522925526","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522925526?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:18","pubTimestamp":1743157121,"startTime":"0","endTime":"0","summary":"Zhejiang Langhua Pharmaceutical, a wholly owned subsidiary of Viva Biotech, , passed the current good manufacturing practices  onsite inspection conducted by the US Food and Drug Administration , according to a Thursday bourse filing.The pharmaceutical company recently received the establishment inspection report from the US FDA, confirming the inspection's completion in line with the Code of Federal Regulations Title 21 .The inspection, done in the second half of 2024, covered quality systems, materials, production, packaging and labeling systems, equipment and facilities, and laboratory control.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1141","BK1576","01873"],"gpt_icon":0},{"id":"2522093543","title":"Press Release: Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2522093543","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522093543?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:30","pubTimestamp":1743082200,"startTime":"0","endTime":"0","summary":"Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D. Highlights of Annual Results for the Year Ended December 31, 2024. Net profit recorded RMB222.0 million, a significant turnaround from a year ago. Adjusted Non-IFRS net profit recorded RMB314.6 million, a YOY increase of nearly 50.6%.CRO Revenue Growth Improved Significantly Improving in the Second Half of the Year to Sustain a Recovery Momentum Ahead. In 2024, the revenue of the Company's CRO business decreased by approximately 4.0% to RMB810.9 million from RMB844.9 million in the same period of last year, while the corresponding adjusted gross profit decreased by approximately 1.9% to RMB357.1 million from RMB363.8 million in the same period of last year. The decrease in CRO revenue in 2024 as compared to previous years was mainly attributable to the short-term impact of the global biopharmaceutical investment and financing pressure in 202","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","SSI","BK1141","BK1576"],"gpt_icon":0},{"id":"2522308588","title":"BRIEF-Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2522308588","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522308588?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:43","pubTimestamp":1743079380,"startTime":"0","endTime":"0","summary":"BRIEF-Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua PharmaceuticalMarch 27 (Reuters) - VIVA Biotech Holdings 1873.HK:PASSING OF U.S. FDA ON-SITE INSPECTION BY LANGHUA PHARMACEUTICALFurther company coverage: 1873.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA0MQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1141","BK1576"],"gpt_icon":0},{"id":"2522735933","title":"VIVA Biotech - Passing of U.S. FDA on-Site Inspection by Langhua Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2522735933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522735933?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:55","pubTimestamp":1743072932,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA0MQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","BK1576","01873"],"gpt_icon":0},{"id":"2522837807","title":"VIVA Biotech Holdings FY Revenue RMB 1,986.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522837807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522837807?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:52","pubTimestamp":1743072763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX880ED6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","01873","BK1576"],"gpt_icon":0},{"id":"2522378020","title":"VIVA Biotech Holdings FY Gross Profit RMB 687.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522378020","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522378020?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:52","pubTimestamp":1743072763,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX880ED6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1576","BK1141","01873"],"gpt_icon":0},{"id":"2522322800","title":"BRIEF-Frontage Holdings Corp Posts FY Net Income USD 0.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522322800","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522322800?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:13","pubTimestamp":1743070433,"startTime":"0","endTime":"0","summary":"BRIEF-Frontage Holdings Corp Posts FY Net Income USD 0.6 MillionMarch 27  - Frontage Holdings Corp 1521.HK:FY NET INCOME USD 0.6 MILLION FY REVENUE USD 254.9 MILLIONFY GROSS PROFIT USD 69.8 MILLIONFY ADJUSTED NET INCOME USD 13.2 MILLIONFY EBITDA MARGIN 19.6%FY ADJUSTED EBITDA MARGIN 21.2%FY GROSS MARGIN 27.4%Further company coverage: 1521.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA0PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521","BK1141","BK1583","BK1576"],"gpt_icon":0},{"id":"2522562321","title":"Rpt-Frontage Holdings Corp FY Ebitda Margin 19.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522562321","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522562321?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:13","pubTimestamp":1743070432,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA0PB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","01521","BK1576","BK1583"],"gpt_icon":0},{"id":"2522321595","title":"Corrected-Frontage Holdings Corp FY Net Income USD 0.6 Million (Corrects Amount)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522321595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522321595?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:13","pubTimestamp":1743070430,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA0PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1576","BK1141","BK1583","01521"],"gpt_icon":0},{"id":"2522329175","title":"Frontage Holdings Corp FY Gross Margin 27.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329175?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLXD6D21E:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","BK1576","01521","BK1583"],"gpt_icon":0},{"id":"2522329171","title":"Frontage Holdings Corp FY Revenue USD 254.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329171?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069649,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLXD6D21E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1141","01521","BK1576"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25}]}}